Skip to main content


Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease

Non-alcoholic steatohepatitis or non-alcohlic fatty liver disease

NASH is a chronic liver disease that can progress to becoming a serious illness without proper treatment. NASH can also affect the heart, increasing the risk of an untimely death. Advanced Research Institute is holding clinical trials in Ogden and Sandy, Utah, and Reno, Nevada, to test new drugs to treat NASH.

How Does Nonalcoholic Steatohepatitis Affect Patients?

Nonalcoholic steatohepatitis can eventually destroy the liver, which is necessary to live. Thus, diagnosis and treatment of this disease is critical. However, some patients suffer few, if any, symptoms of nonalcoholic steatohepatitis, delaying their diagnosis.

Up to 25% of the U.S. population suffers from less aggressive forms of nonalcoholic steatohepatitis, known as nonalcoholic fatty liver disease. Early symptoms include fatigue and pain in the upper right abdomen. Symptoms of advanced nonalcoholic steatohepatitis include jaundice, a swollen abdomen and easy bleeding and bruising.

The disease progresses when fatty deposits build up in the liver, causing inflammation and scarring. Scarring of the liver, also known as cirrhosis, is usually associated with alcoholism, but not always.

NASH strikes overweight and obese people more often. Those who have insulin resistance, hypoglycemia or high levels of fat in the blood are also more susceptible. However, it is not known why some people who meet these conditions develop nonalcoholic steatohepatitis while others don’t.


NASH Clinical Trials

Because NASH can develop into a serious — and even fatal — disease, drug companies are working on creating new drugs to fight nonalcoholic steatohepatitis. Once these drugs go through a battery of tests, it is up to the Food and Drug Administration to clear the drug for clinical research trials.

When the drug is cleared, our clinical research company conducts studies to test the drug on a group of volunteers. To participate in a NASH clinical trial, you must be at least 18 years old and diagnosed with NASH. If you have not been diagnosed with NASH but suspect you may have it, contact us for further information.


Benefits of Participating in NASH Clinical Trials

A benefit of participating in a NASH clinical trial is that volunteers get free medical care. This includes doctor visits and tests — all at no cost to you or your insurance company. The purpose of clinical trials is to test the efficacy of the new drug, and if it works, participants in the study are the first people in the U.S. to get to use the drugs. Everyone else has to wait until the drugs come to market.

As a participant in the NASH clinical trials, you also get the satisfaction of helping others who suffer from this disease by assisting with bringing effective drugs to market. You’ll help make people healthier and more comfortable, and you may even contribute to saving lives.

Clinical Research Trials in Utah & Nevada

If you are interested in participating in Advanced Research Institute’s NASH clinical trials in Sandy and Ogden, Utah, and Reno, Nevada, contact us today. We will do a screening to see if you qualify for our clinical research study.